Moreover, HEXA-018 treatment reduced TDP-43-induced neurotoxicity in cells and Drosophila. Therefore, we expect that the novel catechol derivative compound HEXA-018 might be a drug candidate for neurodegenerative diseases associated with TDP-43 accumulation. Here, TARDBP is linked to neurodegenerative disease.